Non US Residents | Contact Us | Site Map | Large Text VersionRegular Text Version

Welcome to Novartis Oncology US - This site is intended for US Residents only

 

 

 

Causes of Cancer

Disease Education

Hypereosinophilic Syndrome (HES)

 

Diagnosis

How is HES diagnosed?

Tests to diagnose HES include a complete blood count and a medical examination to determine whether there is organ damage.

There are 3 requirements for a diagnosis of HES:

  • Eosinophil counts are elevated (more than 1500 per microliter) for at least 6 months
  • Causes such as infection or allergy have been ruled out
  • There is evidence of organ damage

 

What are the prospects for people with HES?

Prospects for people with HES vary from person to person. It depends on how severe the disease is, which bodily organs are affected, and the success of treatment. In some cases, HES may be fatal.

 

Can HES be eliminated from the body?

HES cannot be eliminated, but it can often be treated.

 

How is HES treated?

Treatment of HES depends on which bodily organs are involved and how severe the disease is. The most common treatment for HES consists of high doses of steroids (medications in the cortisone family). Other treatments include medications that suppress the immune system, and anticancer therapies.

 

 previous section | next section 

DISEASE SUPPORT PROGRAMS

Supportive tools and resources designed to meet your specific needs.

PATIENT ASSISTANCE NOW ONCOLOGY

Quick and easy access to Novartis Oncology reimbursement and support programs.

CLINICAL TRIALS

Find information about our Clinical Trials and how to participate.

HEALTHCARE PROFESSIONALS

Healthcare Professionals

Resources for doctors, nurses and office staff from Novartis Oncology.